An innovative diseases diagnosis project got 100 M RUR
LLC UCS company project devoted to the development and creation of an automated system for early cancer diagnosis (EPR analyzer) pilot unit, got 100 M RUR to start mass apparatus production and further development of a diagnostic laboratories network. Six years investment is provided by the SME Bank (Vnesheconombank Group), Russian Construction Bank CJSC and United Consulting Service CJSC (Moscow UCS CJSC).
The total cost of the innovative diseases diagnosis project realization is 119 M RUR, 19 M RUR invested by the company itself.
The project aims to develop and apply an all-purpose unique method with the help of EPR (electron paramagnetic resonance) - spectroscopic determination of changes in albumin transport properties in blood samples. EPR test is a new clinically proven way, the most important features of which are the possibility to diagnose the presence or absence of cancer, treatment and monitoring of relapse after recovery.
Along with the development of the automated system, the researchers are intended to improve the method that allows determining of diagnosed malignancy localization.
The total cost of the innovative diseases diagnosis project realization is 119 M RUR, 19 M RUR invested by the company itself.
The project aims to develop and apply an all-purpose unique method with the help of EPR (electron paramagnetic resonance) - spectroscopic determination of changes in albumin transport properties in blood samples. EPR test is a new clinically proven way, the most important features of which are the possibility to diagnose the presence or absence of cancer, treatment and monitoring of relapse after recovery.
Along with the development of the automated system, the researchers are intended to improve the method that allows determining of diagnosed malignancy localization.
Похожее
Inkuron receives 150 M RUR to develop a new drug against cancer
The winners of Irkutsk Venture Fairs
Microchips for blood test “Semiotic” attracted investments
A project to create a cancer vaccine won Technovations Cup
Sberbank to finance Moscow technopolis pilot project
A portfolio Company SIF RVC receives the resident status of Tomsk SEZ